BAYRY Stock Recent News

BAYRY's first-quarter earnings beat expectations. Revenues miss estimates, mainly due to lower sales of its products in the Crop Science division.

Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company's request to sharply limit litigation that could run into the billions of dollars over disputed claims that its Roundup weedkiller causes cancer.

Bayer on Tuesday posted a slower decline in first-quarter adjusted earnings than the market had feared as strong prescription numbers for new drugs offset a drop in its soy and cotton seed business.

The company stuck to its full-year outlook on better-than-expected sales and adjusted earnings, but posted a fall in net profit.

Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.

Here is how Bayer Aktiengesellschaft (BAYRY) and Boston Scientific (BSX) have performed compared to their sector so far this year.

The company said it will discontinue certain production activities at its Dormagen and Frankfurt am Main sites.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences.

ST. LOUIS--(BUSINESS WIRE)--Corn rootworm remains one of the most damaging pests in U.S. corn production, causing an estimated $1 billion in losses each year. To help farmers get ahead of this underground threat, Bayer is launching its eighth year of The Watch, a farmer-first program that offers free tools, education and expert support to monitor corn rootworm pressure and make proactive management decisions. “Corn rootworm is a yield-robbing pest that attacks at every stage of its life cycle —.

DALLAS--(BUSINESS WIRE)--Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to pull its popular Roundup weedkiller from the market amid ongoing litigation. Video of the plaintiffs' attorneys' reactions is available here. Speaking at Bayer's annual shareholders meeting, CEO Bill Anderson warned that continued lawsuits could make it financially unsustainable for the company to c.